Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Shrapnel hits across central Israel, injuring several, causing property damage - 2Tech Devices 2023: The Most blazing Arrivals of the Year
- 3Flourishing in Retirement: Individual Accounts of Post-Vocation Satisfaction
- 4SUVs Known for Their Looks As opposed to Their Capacity
- 5Rediscovering Experience Through Excursions: Individual Travel Stories
- From ‘Project Hail Mary’ to Artemis II, spaceflight captures audiences when it centers on people because human space travel is hazardous
- Overseeing Individual budgets Successfully
- A few Up-to-date Sacks - Stylish Young ladies Shouldn't Miss
- Creative Tech Contraptions That Will Work on Your Life
- Air New Zealand cuts flights and hikes fares as fuel prices surge
- This Week In Space podcast: Episode 204 — A New NASA
- Etymological Investigation Disclosed: A Survey of \Dominating New Tongues\ Language Learning Application
- BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet
- Cyber Monday Paramount+ deal: Save 50% and stream these buzzy Taylor Sheridan shows
